bluedoor data·H-1B Jobs API·bluedoor.sh ->

Home / Companies / Repertoire Immune Medicines Inc / Trends

Repertoire Immune Medicines Inc H-1B trends

Quarterly LCA aggregate trend points for Repertoire Immune Medicines Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.

Summary

H-1B LCA filings for Repertoire Immune Medicines Inc span 2020 Q3 to 2026 Q2, peaking at 5 filings in 2022 Q3.

The most recent reported period (2026 Q2) shows 2 filings.

LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.

PeriodLCA countRole titlesSOC codesAvg wage lowAvg prevailingCertifiedCertification rate
2020 Q3333$90,233$82,0283100.0%
2021 Q2111$115,000$106,7461100.0%
2021 Q3333$136,667$127,8723100.0%
2022 Q1111$100,000$84,4481100.0%
2022 Q3531$74,400$58,6775100.0%
2023 Q2222$125,374$111,3642100.0%
2023 Q4211$94,000$91,3742100.0%
2024 Q4111$118,470$111,2381100.0%
2025 Q2111$90,000$85,8421100.0%
2025 Q4222$135,000$114,8682100.0%
2026 Q2222$112,500$102,7212100.0%

Frequently asked questions

How have H-1B filings for Repertoire Immune Medicines Inc changed over time?
H-1B LCA filings for Repertoire Immune Medicines Inc span 2020 Q3 to 2026 Q2, peaking at 5 filings in 2022 Q3. The most recent reported period (2026 Q2) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API

Rendered from the bluedoor H-1B Jobs API. Reproduce it:

GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=repertoire+immune+medicines+inc&metric=lca_countJSON